Is IMA or IMMX more undervalued in 2026?

CirclFi compares ImageneBio, Inc. (IMA) and Immix Biopharma, Inc. (IMMX) using 13 institutional-grade valuation models. IMA has a Quality of Company score of 5.8/10 while IMMX scores 5.1/10.

Which is a better buy — IMA or IMMX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IMA and IMMX valuations compare?

IMA at $5.92 and IMMX at $8.84 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IMA vs IMMX Valuation Comparison 2026 — Intrinsic Value Analysis

IMA

Biotechnology

ImageneBio, Inc.

Quality

5.8

out of 10

Value Trap

LOW

Price

$5.92

Last close

Models

11/13

Active

IMMX

Biotechnology

Immix Biopharma, Inc.

Quality

5.1

out of 10

Value Trap

LOW

Price

$8.84

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	IMA Fair Value	IMA Upside	IMMX Fair Value	IMMX Upside
Bayesian DCF	Intrinsic	$6.30	+11.4%	$2.98	-66.3%
Earnings Power Value	Intrinsic	$8.75	+54.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.31	-94.8%	$1.23	-86.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMA vs IMMX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMA vs IMMX — Which Stock Is More Undervalued?

IMA scores higher with a 5.8/10 quality rating vs IMMX's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ImageneBio, Inc. (IMA) and Immix Biopharma, Inc. (IMMX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMA currently trades at $5.92 with a QOC of 5.8/10, while IMMX trades at $8.84 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).